Michael Carter - Director, Oncternal Therapeutics, Inc

As of May 27, 2021


Michael Carter Net Worth

  • Net worth is estimated to be at least $146.77K
  • Owns at least 71,947 units of Oncternal Therapeutics, Inc stock

Michael Carter Trading

  • Largest purchase of shares was 71,429 units , worth over $150K on September 2, 2020
  • In total has made about 4 transactions over 2 years
  • Usually trades in September, with the busiest year in 2020
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

Michael Carter Mailing Address

  • Mailing address is C/o Cancer Vax Corp 2110 Rutherford Road Carlsbad CA 92008 CA

Oncternal Therapeutics, Inc Insider Trading

  • The most recent transaction was 3,669 units sold on July 2, 2021 by David Hale worth over $17.43K
  • In the last year, insiders at Oncternal Therapeutics, Inc sold an estimated value of $17.43K and bought an estimated value of $2.78M
  • The most active traders are James Breitmeyer, Chief Executive Officer,  David Hale, Director,  and Richard Vincent, Chief Financial Officer
  • Insider trading is most common in June, with the busiest year in 2019

Oncternal Therapeutics, Inc. Insider Trades

Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1